186 related articles for article (PubMed ID: 19549717)
1. Differential modification of Cys10 alters transthyretin's effect on beta-amyloid aggregation and toxicity.
Liu L; Hou J; Du J; Chumanov RS; Xu Q; Ge Y; Johnson JA; Murphy RM
Protein Eng Des Sel; 2009 Aug; 22(8):479-88. PubMed ID: 19549717
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of amyloid beta fibril formation by monomeric human transthyretin.
Garai K; Posey AE; Li X; Buxbaum JN; Pappu RV
Protein Sci; 2018 Jul; 27(7):1252-1261. PubMed ID: 29498118
[TBL] [Abstract][Full Text] [Related]
3. A Cyclic Peptide Mimic of the β-Amyloid Binding Domain on Transthyretin.
Cho PY; Joshi G; Boersma MD; Johnson JA; Murphy RM
ACS Chem Neurosci; 2015 May; 6(5):778-89. PubMed ID: 25713928
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin variants with improved inhibition of β-amyloid aggregation.
Mangrolia P; Yang DT; Murphy RM
Protein Eng Des Sel; 2016 Jun; 29(6):209-218. PubMed ID: 27099354
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers.
Du J; Murphy RM
Biochemistry; 2010 Sep; 49(38):8276-89. PubMed ID: 20795734
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin-derived peptides as β-amyloid inhibitors.
Cho PY; Joshi G; Johnson JA; Murphy RM
ACS Chem Neurosci; 2014 Jul; 5(7):542-51. PubMed ID: 24689444
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of cellular toxicity of amyloid-β by dissociated transthyretin.
Cao Q; Anderson DH; Liang WY; Chou J; Saelices L
J Biol Chem; 2020 Oct; 295(41):14015-14024. PubMed ID: 32769117
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
[TBL] [Abstract][Full Text] [Related]
9. Transthyretin Interferes with Aβ Amyloid Formation by Redirecting Oligomeric Nuclei into Non-Amyloid Aggregates.
Nilsson L; Pamrén A; Islam T; Brännström K; Golchin SA; Pettersson N; Iakovleva I; Sandblad L; Gharibyan AL; Olofsson A
J Mol Biol; 2018 Aug; 430(17):2722-2733. PubMed ID: 29890120
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin as both a sensor and a scavenger of β-amyloid oligomers.
Yang DT; Joshi G; Cho PY; Johnson JA; Murphy RM
Biochemistry; 2013 Apr; 52(17):2849-61. PubMed ID: 23570378
[TBL] [Abstract][Full Text] [Related]
11. Retinol-Binding Protein Interferes with Transthyretin-Mediated β-Amyloid Aggregation Inhibition.
Mangrolia P; Murphy RM
Biochemistry; 2018 Aug; 57(33):5029-5040. PubMed ID: 30024734
[TBL] [Abstract][Full Text] [Related]
12. [Compensatory function of transthyretin in Alzheimer's disease].
Shwartsman AL; Sarantseva SV
Tsitologiia; 2011; 53(10):772-7. PubMed ID: 22232933
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of inhibition of beta-amyloid aggregation by transthyretin.
Liu L; Murphy RM
Biochemistry; 2006 Dec; 45(51):15702-9. PubMed ID: 17176092
[TBL] [Abstract][Full Text] [Related]
14. Copper mediated amyloid-β binding to Transthyretin.
Ciccone L; Fruchart-Gaillard C; Mourier G; Savko M; Nencetti S; Orlandini E; Servent D; Stura EA; Shepard W
Sci Rep; 2018 Sep; 8(1):13744. PubMed ID: 30213975
[TBL] [Abstract][Full Text] [Related]
15. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.
Köppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hähnel A; Klehm J; Kriegeskorte MC; Hartlage-Rübsamen M; Morawski M; von Hörsten S; Demuth HU; Roßner S; Schilling S
Molecules; 2020 Jan; 25(3):. PubMed ID: 32013170
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
Alemi M; Silva SC; Santana I; Cardoso I
CNS Neurosci Ther; 2017 Jul; 23(7):605-619. PubMed ID: 28570028
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
[TBL] [Abstract][Full Text] [Related]
18. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin Mimetics as Anti-β-Amyloid Agents: A Comparison of Peptide and Protein Approaches.
Pate KM; Kim BJ; Shusta EV; Murphy RM
ChemMedChem; 2018 May; 13(9):968-979. PubMed ID: 29512286
[TBL] [Abstract][Full Text] [Related]
20. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
